Birchview Capital’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Hold |
6,000
| – | – | 0.62% | 36 |
|
|
2025
Q1 | $700K | Buy |
6,000
+2,000
| +50% | +$233K | 0.61% | 27 |
|
|
2024
Q4 | $338K | Hold |
4,000
| – | – | 0.28% | 46 |
|
|
2024
Q3 | $359K | Hold |
4,000
| – | – | 0.31% | 40 |
|
|
2024
Q2 | $322K | Hold |
4,000
| – | – | 0.3% | 42 |
|
|
2024
Q1 | $319K | Buy |
+4,000
| New | +$319K | 0.26% | 46 |
|